Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. - Wikidata - wikimedia - TriplyDB

Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.

Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.

http://www.wikidata.org/entity/Q36370602

about

Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity Interferon-induced protein IFIT4 is associated with systemic lupus erythematosus and promotes differentiation of monocytes into dendritic cell-like cells Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus Cross-regulation of TNF and IFN-alpha in autoimmune diseases A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity Microarray analysis of gene expression in lupus Interpreting interest in interferon-alpha Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway Breakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic Cells SLE-associated risk factors affect DC function Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus The antigen presenting cells instruct plasma cell differentiation Intracellular nucleic acid sensors and autoimmunity TLRs and interferons: a central paradigm in autoimmunity Sexual dimorphism in autoimmunity Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity Emerging therapies for systemic lupus erythematosus--focus on targeting interferon-alpha TLR ligands up-regulate Trex1 expression in murine conventional dendritic cells through type I Interferon and NF-κB-dependent signaling pathways The pathogenesis of systemic lupus erythematosus—an update The role of dendritic cells in autoimmunity Type I interferon receptor deficiency prevents murine Sjogren's syndrome Distinct regulation of murine lupus susceptibility genes by the IRF5/Blimp-1 axis Aim2 deficiency in mice suppresses the expression of the inhibitory Fcgamma receptor (FcgammaRIIB) through the induction of the IFN-inducible p202, a lupus susceptibility protein Aim2 deficiency stimulates the expression of IFN-inducible Ifi202, a lupus susceptibility murine gene within the Nba2 autoimmune susceptibility locus.Constitutive phosphorylation of interferon receptor A-associated signaling proteins in systemic lupus erythematosus.Genomic-based high throughput screening identifies small molecules that differentially inhibit the antiviral and immunomodulatory effects of IFN-alpha.TLRs and IFNs: critical pieces of the autoimmunity puzzle Autoimmunity-associated protein tyrosine phosphatase PEP negatively regulates IFN-α receptor signaling Stage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus.Mutually positive regulatory feedback loop between interferons and estrogen receptor-alpha in mice: implications for sex bias in autoimmunity.Disruption of mutually negative regulatory feedback loop between interferon-inducible p202 protein and the E2F family of transcription factors in lupus-prone mice.Bacterial amyloid curli acts as a carrier for DNA to elicit an autoimmune response via TLR2 and TLR9 Blood gene expression profiling in pediatric systemic lupus erythematosus and systemic juvenile idiopathic arthritis: from bench to bedside.New roles for the major human 3'-5' exonuclease TREX1 in human disease.Marginal zone precursor B cells as cellular agents for type I IFN-promoted antigen transport in autoimmunity.Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages A genomic approach to human autoimmune diseases.Mediation of nonerosive arthritis in a mouse model of lupus by interferon-alpha-stimulated monocyte differentiation that is nonpermissive of osteoclastogenesis.IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus

P2860

Q22306446-71D4984F-7F95-4551-AB82-B3D7CABC6114 Q24323367-F3E72012-09FD-4997-B058-078D17D7F90F Q24530690-1CD8EB19-4EC8-4FF6-8417-363A23A6D401 Q24556513-CF5DAF15-FC46-48F9-A829-74D9CB6B9D5C Q24673016-42878B71-0109-443B-BACC-559408A594FB Q24795089-27BC8218-25F4-4630-AFEF-729EB37FAB29 Q24797820-2C4DFB19-3D26-4344-8E51-B5D03212B67D Q26746697-83D49267-429E-4390-B565-DEB228B61B5D Q26748941-B32B673D-D179-41C2-9437-8C51945543C8 Q26774797-9F191439-C1C5-4AF8-A7E4-BCDE61C6CFC3 Q26822662-97CF980E-94B0-4DD6-BEF5-7EA172804474 Q26995780-7CE8C09B-579D-49E4-AC10-740F17E7352C Q26997316-70905FA4-FAA9-4601-8C90-211DB30C03F0 Q27023982-057D3164-B72A-4788-A570-9553BF51CECC Q28080459-318E2C27-32DF-44A7-81A0-C1325965FE6C Q28246851-C7CA7BEA-BC03-46B5-9BBB-6DB85C78A1E8 Q28265144-5064A717-0B96-4585-B750-22488DA8C857 Q28510527-B479B808-0B5E-415F-9D97-9DD9F1A133C1 Q29394347-DD2B7A20-83EC-443B-AACD-71A217F2A73B Q30047565-5413E04E-734A-4AE5-89A3-B12149F6D0E3 Q30413385-06F88F29-95E2-47F3-82AF-9DB8C5727835 Q30423162-6ACC46EA-8F3B-4F93-9BF0-A7EB9D0EBE24 Q30426448-A1A452F4-5E59-4F5C-88C4-FF61A880962F Q30429300-B0C76330-3B1B-4D6D-BB90-8535E620C278 Q31080044-10F4CC48-976F-4E64-9639-4871306D48B3 Q33334070-94BAB738-903D-4FD3-9210-6D66799F9712 Q33354714-AE42EACA-0E8E-4D13-977A-A5EB9BA6BB8F Q33423646-1D7C8816-A389-4F3F-8F08-532540B88EA0 Q33496779-13178C77-733E-4620-8412-C43088DB4ED1 Q33595836-0EC5DCBB-C115-4EA7-97DF-544E778FBAAA Q33605468-7A560B8C-590E-4FF8-AC0D-15A48678851E Q33606019-E0E73BD2-E649-4F6B-A931-A8B7C0C28E80 Q33622723-43A43EF3-C53B-4444-BD5C-35D261F3D3B9 Q33671295-C792BA10-E4A1-4807-AAAD-CA223AFE3B3C Q33694922-2AD253A1-E64A-456B-9B02-BD1E1BE26A8A Q33731760-4AC65B44-C403-4E07-9B58-6E7CBBBEF71C Q33733803-DE831293-EC83-465B-BA22-D2B38BA48E2B Q33762839-EC4FD3DF-8AE3-4A0E-89DF-7A7B5FF989E7 Q33790174-58A09910-75D1-41E5-B949-7B0217D0F6B1 Q33804141-18EDA02D-9072-422A-A692-C0CDC48ABB3A

P2860

Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.

http://www.wikidata.org/entity/Q36370602

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.

@ast

Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.

@en

type

label

Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.

@ast

Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.

@en

prefLabel

Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.

@ast

Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.

@en

P1433

Q36370602-74538B72-657C-42D1-9F92-D2D7A27CD4CB

P1476

Q36370602-00957C4E-3ADD-45E9-833E-D05733165BF3

P2093

Q36370602-076F92F4-DC2B-41E9-98DD-5106E7AD053A

Q36370602-0A8087F9-260A-4B34-B3DA-B0340817D061

Q36370602-2A46031B-DDDF-491C-ABF4-812B4436356F

Q36370602-945C03EF-571C-444B-A959-2C21C069D60E

Q36370602-AD33D4E0-B25B-477D-8FB8-5ABB4B22A104

Q36370602-C898EA97-8589-4E9E-AEFF-E1817753C45D

Q36370602-D6677304-6057-41C3-BC70-26D8D54548A8

P2860

Q36370602-03E16852-1F00-4314-A6FC-2ACEFC6833C5

Q36370602-07F4F5FC-AFE1-432E-91E4-1223D1A78E09

Q36370602-0AEDD0EF-B7F5-4FE2-8A98-E6F4101D6FF3

Q36370602-0C802F77-72CE-419B-BF3D-C6FBC80727DC

Q36370602-0D6403FA-A1B9-4402-A2B7-FFF92E1F10E2

Q36370602-0F937C3E-B44E-4A8D-8D49-F16E1E60EF55

Q36370602-12261D54-041C-46E6-8D1F-FB779A205076

Q36370602-192F75BD-B872-4DD9-B4D4-899C8E117976

Q36370602-20EDBC89-280F-45C8-A136-DF4B5F142764

Q36370602-2EB64DDD-667B-4E94-BA98-753495983471

P304

Q36370602-0C7765D5-EA66-4FB9-86BB-FAF51303C411

P31

Q36370602-FB64250D-FF38-4803-BE5D-B38E1F107327

P356

Q36370602-4660975B-5FF4-4E49-B1A4-5EAD62F64A2D

P407

Q36370602-A1A24144-69A2-4BB1-8C1E-1CBEFAB41227

P433

Q36370602-1368D26A-9B49-4748-A5FB-9835D0BF2FC2

P478

Q36370602-2ECAE7B8-F828-4894-8AE2-1EBBA27DDD41

P577

Q36370602-C27C73A3-8DA4-4F98-88BD-A8C13CBD21B5

P5875

Q36370602-E629621A-35A6-4A82-ADB5-E31E315D3268

P698

Q36370602-14343A01-57AC-448A-A4AA-29C55BB86BB8

P932

Q36370602-017620F4-52EB-44C0-ABCC-1C635A35CF61

P356

P1433

Journal of Experimental Medicine

P1476

Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.

@en

P2093

Argyrios N Theofilopoulos

http://www.w3.org/2001/XMLSchema#string

Divaker Choubey

http://www.w3.org/2001/XMLSchema#string

Dwight H Kono

http://www.w3.org/2001/XMLSchema#string

Katarina M Haraldsson

http://www.w3.org/2001/XMLSchema#string

Marie-Laure Santiago-Raber

http://www.w3.org/2001/XMLSchema#string

Roberto Baccala

http://www.w3.org/2001/XMLSchema#string

Timothy A Stewart

http://www.w3.org/2001/XMLSchema#string

P2860

Functional role of type I and type II interferons in antiviral defense

The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity.

CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity

IRF family of transcription factors as regulators of host defense

Activation and differentiation of autoreactive B-1 cells by interleukin 10 induce autoimmune hemolytic anemia in Fas-deficient antierythrocyte immunoglobulin transgenic mice

Cyclins and cell cycle checkpoints.

Natural adjuvants: endogenous activators of dendritic cells.

Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen.

Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy.

Genetics of systemic autoimmunity in mouse models of lupus.

P304

777-788

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20021996

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

197

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10850606

http://www.w3.org/2001/XMLSchema#string

P698

12642605

http://www.w3.org/2001/XMLSchema#string

P932

2193854

http://www.w3.org/2001/XMLSchema#string